Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,465 signal articles · 149 in last 24h · 154,208 total before filter · latest 50m ago
149last 24h
868last 7d
144● bullish (7d)
96● bearish (7d)
214publishers
AllMacro208Earnings108M&A125Regulatory21Product21Analyst18
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Bull Case For Alibaba (BABA) Could Change Following New Lawsuits Targeting Its AI And Disclosures
Simply Wall St.36d agobearish
The Bull Case For Alibaba (BABA) Could Change Following New Lawsuits Targeting Its AI And Disclosures

Alibaba Group Holding has faced a wave of securities fraud class action lawsuits after the U.S. Department of Defense labeled it a “Chinese military company” and reports emerged of alleged unauthorized use of third-party AI models, raising questions about its regulatory disclosures and AI practices. Beyond the legal risk, these cases highlight how deeply Alibaba’s emerging AI business is now intertwined with geopolitical scrutiny and compliance expectations in key markets. We’ll now examine...

Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit?
Simply Wall St.37d agobearish
Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit?

Hims & Hers Health (NYSE:HIMS) is facing a new consumer class action lawsuit alleging misrepresentation of user privacy and unauthorized sharing of sensitive health data. The lawsuit follows a recent FTC civil enforcement action against the company that raised similar concerns about handling of consumer health information. Plaintiffs claim the company misled users about how their health data would be used and shared, potentially affecting customer trust and future regulatory scrutiny. As...

UnitedHealth Group (UNH) Hit With Investor Lawsuit Over Governance And Cybersecurity Claims
Simply Wall St.37d agobearish
UnitedHealth Group (UNH) Hit With Investor Lawsuit Over Governance And Cybersecurity Claims

UnitedHealth Group (NYSE:UNH) is facing a major investor lawsuit alleging longstanding corporate governance and cybersecurity failures tied to its Change Healthcare acquisition. The complaint claims oversight gaps at UnitedHealth contributed to what plaintiffs describe as the largest healthcare data breach in U.S. history. Investors argue that weaknesses in internal controls and board level risk management left sensitive patient and claims data exposed. The case raises fresh questions for...

Monolithic Power Systems (MPWR) Is Facing A Shareholder Governance Investigation
Simply Wall St.37d agobearish
Monolithic Power Systems (MPWR) Is Facing A Shareholder Governance Investigation

A law firm has launched a shareholder investigation into Monolithic Power Systems (NasdaqGS: MPWR) over potential breaches of fiduciary duty by officers and directors. The review focuses on whether corporate governance practices have adequately protected shareholder interests and complied with legal obligations. The outcome could influence future governance reforms and shareholder remedies, which may affect investor views on management oversight. For a broader view on how corporate...

The Morning Risk Report: L3Harris Ousts CEO After Investigation Into Conduct
The Wall Street Journal37d agobearish
The Morning Risk Report: L3Harris Ousts CEO After Investigation Into Conduct

L3Harris Technologies, the company that overhauled a Qatari plane now used as Air Force One, has replaced Christopher Kubasik as chairman and chief executive after an investigation determined he violated the defense contractor’s code of conduct. Kubasik’s alleged conduct didn’t involve and has no impact on the Melbourne, Fla., company’s financial reporting, controls, customer relationships or operational performance, L3Harris said Monday. Explanation: The company didn’t give details on when it received a report of the potential violation.

Guardant Health (GH) Surges on FDA Approval and Cancer Screening Momentum
Insider Monkey38d agobullish
Guardant Health (GH) Surges on FDA Approval and Cancer Screening Momentum

Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 14.69% in the second quarter of 2026, slightly trailing the 15.20% gain of the S&P 500 Index as market performance remained highly concentrated in artificial intelligence (AI)-related […]

Stellantis Recalls Almost 1 Million Cars; Stock Falls To All-Time Low
Investor's Business Daily38d agobearish
Stellantis Recalls Almost 1 Million Cars; Stock Falls To All-Time Low

Stellantis stock tumbled to a new low on Monday after it announced a recall of almost 1 million vehicles worldwide. The recall is a software issue in the radio systems of Jeep, Dodge and Chrysler brand cars. The glitch interferes with their rear view cameras, the company said, but will be fixed via an over-the-air software update.

Peabody Energy (BTU) Faces Centurion Lawsuit, Is The Stock Still Cheap?
Simply Wall St.38d agobearish
Peabody Energy (BTU) Faces Centurion Lawsuit, Is The Stock Still Cheap?

Why the Centurion mine lawsuit matters for Peabody Energy Peabody Energy (BTU) is under pressure after investors filed a securities class action lawsuit tied to earlier statements about production prospects at its Centurion premium hard coking coal mine. The complaint focuses on whether disclosures around Centurion’s commissioning challenges and shipment volumes gave investors a fair picture of operational risks and potential financial impact. See our latest analysis for Peabody...

Is Peabody Energy’s (BTU) Centurion Lawsuit Quietly Reframing Its Long-Term Coal Production Narrative?
Simply Wall St.39d agobearish
Is Peabody Energy’s (BTU) Centurion Lawsuit Quietly Reframing Its Long-Term Coal Production Narrative?

Peabody Energy Corporation is facing a securities fraud class action in the Eastern District of Missouri, alleging it misled investors about production plans and commissioning challenges at its flagship Centurion premium hard coking coal mine, after reporting much lower-than-touted output in early 2026. Alongside the lawsuit, Peabody also filed a US$70.56 million shelf registration for 3,000,000 common shares tied to an ESOP-related offering, raising questions about capital needs,...

Major ice cream brand files Chapter 11 bankruptcy after lawsuit
TheStreet40d agobearish
Major ice cream brand files Chapter 11 bankruptcy after lawsuit

Enjoying a serving of frozen dessert on a hot summer day, or at any time for that matter, has grown in popularity as ice cream store industry growth rose by 5.8% to $7.4 billion in the five years through 2025, according to IBISWorld. The industry grew by 0.9% in 2025 alone. Ice cream company ...

Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands
Simply Wall St.41d agoneutral
Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands

Bristol-Myers Squibb stock has delivered a 38.1% gain over the past year, while valuation work using a Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples both currently point to the shares trading at a discount to that estimate. For investors, that combination of strong recent returns and a still supportive valuation framework raises the question of how much margin of safety may remain in the current price. The 38.1% one year return shows that sentiment toward...

Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?
Simply Wall St.41d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?

Bristol Myers Squibb (BMY) is back in focus after the FDA granted accelerated approval for ZENBEXUS in a multiple myeloma combination regimen, introducing the first approved CELMoD therapy in this disease setting. See our latest analysis for Bristol-Myers Squibb. The ZENBEXUS approval lands at a time when Bristol-Myers Squibb’s momentum has picked up, with the share price at US$64.65 and a 30 day share price return of 13.52%. That builds on a 20.93% year to date share price return and a...

Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line Performance
Insider Monkey42d agoneutral
Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line Performance

Sycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for “Sycamore Mid Cap Value Equity Strategy”. A copy of the letter can be downloaded here. Sycamore Capital’s Mid Cap Value investment team focuses on a bottom-up approach to identify undervalued businesses with growth potential. In Q2 2026, the strategy […]

Is Charles Schwab (SCHW) At Greater Risk After A 13,000 Customer Lawsuit?
Simply Wall St.42d agobearish
Is Charles Schwab (SCHW) At Greater Risk After A 13,000 Customer Lawsuit?

Charles Schwab (NYSE:SCHW) faces ongoing litigation from Linqto over an alleged contractual breakdown tied to bankruptcy trust management affecting more than 13,000 customers. Linqto is seeking damages it claims stem from Schwab's role in the disputed trust arrangements during Linqto's bankruptcy process. The dispute centers on alleged contractual breaches that Linqto argues caused substantial harm to impacted customer accounts. The case is drawing attention because of potential reputational...